Locations
New York, NY, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series B
founded in
2019
Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. .
Something looks off?On-site & Remote